Viewing StudyNCT00370383



Ignite Creation Date: 2024-05-05 @ 5:01 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00370383
Status: COMPLETED
Last Update Posted: 2012-08-07
First Post: 2006-08-30

Brief Title: A Study Comparing Sequential Satraplatin Erlotinib to Erlotinib in Unresectable Stage 34 Non-small-cell Lung Cancer NSCLC
Sponsor:
Organization: Agennix

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 100
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: